(Q40311508)

19 September 2017

title

Is Helicobacter pylori a cause of atrial fibrillation? (English)

1 reference

Annibale Sandro Montenero

19 September 2017

1 reference

1 reference

series ordinal

2

object named as

Annibale Sandro Montenero

1 reference

19 September 2017

Peter Andrew

1

1 reference

19 September 2017

publication date

1 July 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

2

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

429-439

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

19 September 2017

1 reference

Asymptomatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Epidemiology and economic impact of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Atrial fibrillation and stroke : concepts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Risk of thromboembolism in acute atrial fibrillation or atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Lessons from the Stroke Prevention in Atrial Fibrillation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

International comparison of stroke cost studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Is atrial fibrillation a genetic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Genetic aspects of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Identifying and understanding the role of pulmonary vein activity in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Drug-induced atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Interrelationships between the autonomic nervous system and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Mechanisms of atrial fibrillation: lessons from studies in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

The natural history of lone atrial fibrillation. A population-based study over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

New antiarrhythmic drugs for prevention of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Pharmacologic management of atrial fibrillation: current therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Catheter and surgical ablation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Electrical cardioversion of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5-year follow-up of 268 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Errors and pitfalls in the non-invasive management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Evaluation of pulmonary vein stenosis after catheter ablation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Limitations to antiarrhythmic drug use in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Economic burden and co-morbidities of atrial fibrillation in a privately insured population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Cost-effectiveness of rhythm versus rate control in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Rate control vs. pulmonary vein isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Cost effectiveness of therapies for atrial fibrillation. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Prevention of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Helicobacter pylori and atrial fibrillation: a possible pathogenic link

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Atrial fibrillation in trauma patients requiring intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Fecal and oral shedding of Helicobacter pylori from healthy infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Helicobacter pylori: epidemiology and routes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Relation of Helicobacter pylori infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Association of virulent Helicobacter pylori strains with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

The story so far: Helicobacter pylori and gastric autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Autoantibodies to gastric mucosa in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Identification and regulation of the gastric H+/K+‐ATPase in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Clinical and therapeutic significance of the Na+,K+ pump*.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Treatment of H. pylori infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Helicobacter pylori vaccine development: facing the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Extending the cardiovascular benefits of omega-3 Fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

Helicobacter pyloriInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.429

21 January 2018

Identifiers

DOI

10.2217/14796678.2.4.429

1 reference

19 September 2017

1 reference